High level of medication adherence is required to lower mortality in patients with chronic hepatitis B taking entecavir: A nationwide cohort study-Reference-Cited by-同舟云学术

High level of medication adherence is required to lower mortality in patients with chronic hepatitis B taking entecavir: A nationwide cohort study

Published:2020-10-29 Issue:2 Volume:28 Page:353-363
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Lee Jayoun¹^ORCID,Cho Songhee¹^ORCID,Kim Hyo Jeong¹^ORCID,Lee Hangil²^ORCID,Ko Min Jung¹^ORCID,Lim Young‐Suk¹³^ORCID

Affiliation:

1. Division for Healthcare Technology Assessment Research National Evidence‐based Healthcare Collaborating Agency Seoul Republic of Korea

2. Seoul‐Gangwon Regional Headquarters National Health Insurance Service Seoul Republic of Korea

3. Department of Gastroenterology Liver Center Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

Funder

National Evidence-based Healthcare Collaborating Agency

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13418

Reference48 articles.

1. Hepatitis B virus infection

2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

3. World Health Organization.Global health sector strategy on viral hepatitis 2016–2021. Sixth‐ninth World Health Assembly provisional agenda item 151 Document A69/32.2016.

4. AASLD guidelines for treatment of chronic hepatitis B

5. WHO.Guidelines for the prevention care and treatment of persons with chronic hepatitis B infection 2015. Available at:http://apps.who.int/iris/handle/10665/154590. Date accessed: Oct. 12 2016. 2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment decisions based on HBV DNA;Journal of Viral Hepatitis;2024-05-24

2. Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial;Trials;2024-01-05

3. Progress of Research on the Current Status and Influencing Factors of Medication Adherence in Chronic Hepatitis B Patients;Advances in Clinical Medicine;2024

4. Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma;Diagnostics;2023-10-14

5. Gray zone of hepatitis B virus infection;Saudi Journal of Gastroenterology;2023-10-09